| 000 | 01504 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513062718.0 | ||
| 264 | 0 | _c19940505 | |
| 008 | 199405s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBetter, M | |
| 245 | 0 | 0 |
_aGelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique properties. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cApr 1994 |
||
| 300 |
_a9644-50 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xmetabolism |
| 650 | 0 | 4 | _aCysteine |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aImmunoglobulin G _xmetabolism |
| 650 | 0 | 4 |
_aImmunotoxins _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 |
_aPlant Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aProtein Engineering |
| 650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacokinetics |
| 650 | 0 | 4 | _aRibosome Inactivating Proteins, Type 1 |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aBernhard, S L | |
| 700 | 1 | _aFishwild, D M | |
| 700 | 1 | _aNolan, P A | |
| 700 | 1 | _aBauer, R J | |
| 700 | 1 | _aKung, A H | |
| 700 | 1 | _aCarroll, S F | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 269 _gno. 13 _gp. 9644-50 |
|
| 999 |
_c8143874 _d8143874 |
||